Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""recurrence"" wg kryterium: Temat

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 6713
Tytuł:
Exposure-safety and exposure-efficacy analyses for tisotumab vedotin for patients with locally advanced or metastatic solid tumors.
Autorzy:
Passey C; Genmab US, Inc., Princeton, New Jersey, USA.
Voellinger J; Seagen Inc., Bothell, Washington, USA.
Gibiansky L; QuantPharm LLC, North Potomac, Maryland, USA.
Gunawan R; Seagen Inc., Bothell, Washington, USA.
Nicacio L; Seagen Inc., Bothell, Washington, USA.
Soumaoro I; Genmab US, Inc., Princeton, New Jersey, USA.
Hanley WD; Seagen Inc., Bothell, Washington, USA.
Winter H; Gilead Sciences, Inc., Foster City, California, USA.
Gupta M; Genmab US, Inc., Princeton, New Jersey, USA.
Pokaż więcej
Źródło:
CPT: pharmacometrics & systems pharmacology [CPT Pharmacometrics Syst Pharmacol] 2023 Sep; Vol. 12 (9), pp. 1262-1273. Date of Electronic Publication: 2023 Jul 26.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Neoplasm Recurrence, Local*
Immunoconjugates*/adverse effects
Adult ; Humans ; Antibodies, Monoclonal, Humanized/adverse effects
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Spatial transcriptomics reveals prognosis-associated cellular heterogeneity in the papillary thyroid carcinoma microenvironment.
Autorzy:
Yan K; Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.
Liu QZ; Chronic Disease Laboratory, Institutes for Life Sciences, South China University of Technology, Guangzhou, China.
Huang RR; Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.
Jiang YH; Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.; Guangdong Provincial Key Laboratory of Artificial Intelligence in Medical Image Analysis and Application, Guangzhou, China.
Bian ZH; School of Biomedical Sciences and Engineering, South China University of Technology, Guangzhou International Campus, Guangzhou, China.
Li SJ; Department of Thyroid Surgery, Guangzhou First People's Hospital, South China University of Technology, Guangzhou, China.
Li L; Medical Research Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China.
Shen F; Department of Thyroid Surgery, Guangzhou First People's Hospital, South China University of Technology, Guangzhou, China.
Tsuneyama K; Department of Pathology and Laboratory Medicine, Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima, Japan.
Zhang QL; Department of Pathology, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China.
Lian ZX; Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China.
Guan H; Department of Endocrinology, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China.
Xu B; Department of Thyroid Surgery, Guangzhou First People's Hospital, South China University of Technology, Guangzhou, China.
Pokaż więcej
Źródło:
Clinical and translational medicine [Clin Transl Med] 2024 Mar; Vol. 14 (3), pp. e1594.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Thyroid Neoplasms*/diagnosis
Thyroid Neoplasms*/genetics
Thyroid Neoplasms*/metabolism
Humans ; Thyroid Cancer, Papillary/genetics ; Thyroid Cancer, Papillary/metabolism ; Thyroid Cancer, Papillary/pathology ; Ligands ; Tumor Microenvironment/genetics ; Neoplasm Recurrence, Local ; Gene Expression Profiling ; Prognosis ; RNA
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Clinical and Laboratory Predictors of Long-Term Outcomes after Catheter Ablation for a Ventricular Electrical Storm.
Autorzy:
Sławiński G; Department of Cardiology and Electrotherapy, Medical University of Gdańsk, Smoluchowskiego 17 Street, 80-214 Gdańsk, Poland.
Hawryszko M; Department of Cardiology and Electrotherapy, Medical University of Gdańsk, Smoluchowskiego 17 Street, 80-214 Gdańsk, Poland.
Dyda-Kristowska J; Department of Cardiology and Electrotherapy, Medical University of Gdańsk, Smoluchowskiego 17 Street, 80-214 Gdańsk, Poland.
Królak T; Department of Cardiology and Electrotherapy, Medical University of Gdańsk, Smoluchowskiego 17 Street, 80-214 Gdańsk, Poland.
Kempa M; Department of Cardiology and Electrotherapy, Medical University of Gdańsk, Smoluchowskiego 17 Street, 80-214 Gdańsk, Poland.
Świetlik D; Division of Biostatistics and Neural Networks, Medical University of Gdańsk, Dębinki 1 Street, 80-211 Gdansk, Poland.
Kozłowski D; Department of Cardiology and Electrotherapy, Medical University of Gdańsk, Smoluchowskiego 17 Street, 80-214 Gdańsk, Poland.
Daniłowicz-Szymanowicz L; Department of Cardiology and Electrotherapy, Medical University of Gdańsk, Smoluchowskiego 17 Street, 80-214 Gdańsk, Poland.
Lewicka E; Department of Cardiology and Electrotherapy, Medical University of Gdańsk, Smoluchowskiego 17 Street, 80-214 Gdańsk, Poland.
Pokaż więcej
Źródło:
Journal of interventional cardiology [J Interv Cardiol] 2024 Feb 05; Vol. 2024, pp. 5524668. Date of Electronic Publication: 2024 Feb 05 (Print Publication: 2024).
Typ publikacji:
Journal Article
MeSH Terms:
Myocardial Ischemia*
Tachycardia, Ventricular*/surgery
Catheter Ablation*/adverse effects
Cardiomyopathies*/etiology
Cardiomyopathies*/surgery
Humans ; Retrospective Studies ; Treatment Outcome ; Recurrence
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
NCAPH drives breast cancer progression and identifies a gene signature that predicts luminal a tumour recurrence.
Autorzy:
Mendiburu-Eliçabe M; Instituto de Biología Molecular y Celular del Cáncer (IBMCC-CIC), Universidad de Salamanca/CSIC, Salamanca, Spain.; Biosanitary Research Institute of Salamanca (IBSAL), Salamanca, Spain.
García-Sancha N; Instituto de Biología Molecular y Celular del Cáncer (IBMCC-CIC), Universidad de Salamanca/CSIC, Salamanca, Spain.; Biosanitary Research Institute of Salamanca (IBSAL), Salamanca, Spain.
Corchado-Cobos R; Instituto de Biología Molecular y Celular del Cáncer (IBMCC-CIC), Universidad de Salamanca/CSIC, Salamanca, Spain.; Biosanitary Research Institute of Salamanca (IBSAL), Salamanca, Spain.
Martínez-López A; Departamento de Bioquímica y Biología Molecular, Facultad de Ciencias Químicas, Universidad Complutense, Madrid, Spain.; San Carlos Health Research Institute (IdISSC), Madrid, Spain.
Chang H; Biological Systems and Engineering Division, Lawrence Berkeley National Laboratory (LBNL), Berkeley, California, USA.; Berkeley Biomedical Data Science Center, Lawrence Berkeley National Laboratory (LBNL), Berkeley, California, USA.
Hua Mao J; Biological Systems and Engineering Division, Lawrence Berkeley National Laboratory (LBNL), Berkeley, California, USA.; Berkeley Biomedical Data Science Center, Lawrence Berkeley National Laboratory (LBNL), Berkeley, California, USA.
Blanco-Gómez A; Instituto de Biología Molecular y Celular del Cáncer (IBMCC-CIC), Universidad de Salamanca/CSIC, Salamanca, Spain.; Biosanitary Research Institute of Salamanca (IBSAL), Salamanca, Spain.
García-Casas A; Departamento de Bioquímica y Biología Molecular, Facultad de Ciencias Químicas, Universidad Complutense, Madrid, Spain.; San Carlos Health Research Institute (IdISSC), Madrid, Spain.
Castellanos-Martín A; Instituto de Biología Molecular y Celular del Cáncer (IBMCC-CIC), Universidad de Salamanca/CSIC, Salamanca, Spain.; Biosanitary Research Institute of Salamanca (IBSAL), Salamanca, Spain.
Salvador N; Departamento de Bioquímica y Biología Molecular, Facultad de Ciencias Químicas, Universidad Complutense, Madrid, Spain.; San Carlos Health Research Institute (IdISSC), Madrid, Spain.
Jiménez-Navas A; Instituto de Biología Molecular y Celular del Cáncer (IBMCC-CIC), Universidad de Salamanca/CSIC, Salamanca, Spain.; Biosanitary Research Institute of Salamanca (IBSAL), Salamanca, Spain.
Pérez-Baena MJ; Instituto de Biología Molecular y Celular del Cáncer (IBMCC-CIC), Universidad de Salamanca/CSIC, Salamanca, Spain.; Biosanitary Research Institute of Salamanca (IBSAL), Salamanca, Spain.
Sánchez-Martín MA; Departamento de Medicina, Universidad de Salamanca, Salamanca, Spain.; Servicio de Transgénesis, Plataforma Nucleus, Universidad de Salamanca, Salamanca, Spain.
Abad-Hernández MDM; Biosanitary Research Institute of Salamanca (IBSAL), Salamanca, Spain.; Departamento de Anatomía Patológica, Universidad de Salamanca, Salamanca, Spain.; Servicio de Anatomía Patológica, Hospital Universitario de Salamanca, Salamanca, Spain.
Carmen SD; Biosanitary Research Institute of Salamanca (IBSAL), Salamanca, Spain.; Departamento de Anatomía Patológica, Universidad de Salamanca, Salamanca, Spain.; Servicio de Anatomía Patológica, Hospital Universitario de Salamanca, Salamanca, Spain.
Claros-Ampuero J; Instituto de Biología Molecular y Celular del Cáncer (IBMCC-CIC), Universidad de Salamanca/CSIC, Salamanca, Spain.; Biosanitary Research Institute of Salamanca (IBSAL), Salamanca, Spain.; Servicio de Oncología, Hospital Universitario de Salamanca, Salamanca, Spain.
Cruz-Hernández JJ; Instituto de Biología Molecular y Celular del Cáncer (IBMCC-CIC), Universidad de Salamanca/CSIC, Salamanca, Spain.; Biosanitary Research Institute of Salamanca (IBSAL), Salamanca, Spain.; Departamento de Medicina, Universidad de Salamanca, Salamanca, Spain.; Servicio de Oncología, Hospital Universitario de Salamanca, Salamanca, Spain.
Rodríguez-Sánchez CA; Instituto de Biología Molecular y Celular del Cáncer (IBMCC-CIC), Universidad de Salamanca/CSIC, Salamanca, Spain.; Biosanitary Research Institute of Salamanca (IBSAL), Salamanca, Spain.; Departamento de Medicina, Universidad de Salamanca, Salamanca, Spain.; Servicio de Oncología, Hospital Universitario de Salamanca, Salamanca, Spain.
García-Cenador MB; Biosanitary Research Institute of Salamanca (IBSAL), Salamanca, Spain.; Departamento de Cirugía, Universidad de Salamanca, Salamanca, Spain.
García-Criado FJ; Biosanitary Research Institute of Salamanca (IBSAL), Salamanca, Spain.; Departamento de Cirugía, Universidad de Salamanca, Salamanca, Spain.
Vicente RS; Departamento de Informática y Automática, Universidad de Salamanca, Salamanca, España.
Castillo-Lluva S; Departamento de Bioquímica y Biología Molecular, Facultad de Ciencias Químicas, Universidad Complutense, Madrid, Spain.; San Carlos Health Research Institute (IdISSC), Madrid, Spain.
Pérez-Losada J; Instituto de Biología Molecular y Celular del Cáncer (IBMCC-CIC), Universidad de Salamanca/CSIC, Salamanca, Spain.; Biosanitary Research Institute of Salamanca (IBSAL), Salamanca, Spain.
Pokaż więcej
Źródło:
Clinical and translational medicine [Clin Transl Med] 2024 Feb; Vol. 14 (2), pp. e1554.
Typ publikacji:
Journal Article
MeSH Terms:
Breast Neoplasms*/drug therapy
Humans ; Mice ; Animals ; Female ; Neoplasm Recurrence, Local/genetics ; Gene Expression Profiling ; Prognosis ; Mice, Transgenic ; Nuclear Proteins/genetics ; Cell Cycle Proteins/genetics
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Are fear of cancer recurrence and fear of progression equivalent constructs?
Autorzy:
Coutts-Bain D; The School of Psychology, University of Sydney, Sydney, New South Wales, Australia.
Sharpe L; The School of Psychology, University of Sydney, Sydney, New South Wales, Australia.
Pradhan P; The School of Psychology, University of Sydney, Sydney, New South Wales, Australia.
Russell H; Ovarian Cancer Australia, Melbourne, Victoria, Australia.
Heathcote LC; Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
Costa D; The School of Psychology, University of Sydney, Sydney, New South Wales, Australia.; Pain Management Research Institute, Royal North Shore Hospital, Sydney, New South Wales, Australia.
Pokaż więcej
Źródło:
Psycho-oncology [Psychooncology] 2022 Aug; Vol. 31 (8), pp. 1381-1389. Date of Electronic Publication: 2022 May 01.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Neoplasm Recurrence, Local*
Phobic Disorders*
Adult ; Fear ; Humans ; Survivors
SCR Disease Name:
Phobia, Specific
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Idiopathic Granulomatous Mastitis.
Autorzy:
Dilaveri C; Mayo Clinic, Department of Medicine, Division of General Internal Medicine, Rochester, USA.
Degnim A; Mayo Clinic, Department of Surgery, Division of Breast and Melanoma Surgical Oncology, Rochester, USA.
Lee C; Mayo Clinic, Department of Radiology, Division of Breast Imaging and Intervention, Rochester, USA.
DeSimone D; Mayo Clinic, Department of Medicine, Division of Infectious Diseases, Rochester, USA.
Moldoveanu D; Mayo Clinic, Department of Surgery, Division of Breast and Melanoma Surgical Oncology, Rochester, USA.
Ghosh K; Mayo Clinic, Department of Medicine, Division of General Internal Medicine, Rochester, USA.
Pokaż więcej
Źródło:
The breast journal [Breast J] 2024 Jan 25; Vol. 2024, pp. 6693720. Date of Electronic Publication: 2024 Jan 25 (Print Publication: 2024).
Typ publikacji:
Journal Article; Review
MeSH Terms:
Granulomatous Mastitis*/diagnosis
Granulomatous Mastitis*/drug therapy
Breast Neoplasms*/diagnosis
Female ; Humans ; Adult ; Neoplasm Recurrence, Local ; Breast/pathology ; Steroids
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Single-cell RNA sequencing reveals SERPINE1-expressing CAFs remodelling tumour microenvironment in recurrent osteosarcoma.
Autorzy:
Huang X; Department of Orthopaedics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Wang L; Department of Orthopaedics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Guo H; Department of Orthopaedics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Zhang W; Department of Endocrinology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Pokaż więcej
Źródło:
Clinical and translational medicine [Clin Transl Med] 2024 Jan; Vol. 14 (1), pp. e1527.
Typ publikacji:
Letter; Research Support, Non-U.S. Gov't
MeSH Terms:
Osteosarcoma*/genetics
Bone Neoplasms*/genetics
Humans ; Tumor Microenvironment/genetics ; Neoplasm Recurrence, Local/genetics ; Sequence Analysis, RNA ; Plasminogen Activator Inhibitor 1/genetics
Raport
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Pre-analytical processing protocol of breast biopsies affects multigene panel results.
Autorzy:
Lima VR; Clinical Analysis Laboratory of the Medical School of the ABC (FMABC) University Center, Santo André, Brazil.
da Costa Aguiar Alves B; Clinical Analysis Laboratory of the Medical School of the ABC (FMABC) University Center, Santo André, Brazil.
Fonseca FLA; Clinical Analysis Laboratory of the Medical School of the ABC (FMABC) University Center, Santo André, Brazil.; Institute of Pharmaceutical Sciences, Federal University of São Paulo (UNIFESP), Diadema, Brazil.
Zveibil DK; Department of Pathology, Medical School of the ABC (FMABC) University Center, Santo André, Brazil.
Del Giglio A; Discipline of Oncology and Hematology, Medical School of the ABC (FMABC) University Center, Santo André, Brazil.
Pokaż więcej
Źródło:
International journal of experimental pathology [Int J Exp Pathol] 2022 Jun; Vol. 103 (3), pp. 112-120.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Breast Neoplasms*/pathology
Neoplasm Recurrence, Local*/drug therapy
Neoplasm Recurrence, Local*/genetics
Neoplasm Recurrence, Local*/pathology
Biopsy ; Chemotherapy, Adjuvant ; Female ; Gene Expression Profiling/methods ; Humans ; Prognosis
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Factors Affecting Recurrence of Idiopathic Granulomatous Mastitis: A Systematic Review.
Autorzy:
Fattahi AS; Endoscopic and Minimally Invasive Research Center, Department of Surgery, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Amini G; Endoscopic and Minimally Invasive Research Center, Department of Surgery, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Sajedi F; Department of Persian Medicine, School of Persian and Complementary Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Mehrad-Majd H; Clinical Research Development Unit, Ghaem Hospital, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Pokaż więcej
Źródło:
The breast journal [Breast J] 2023 Sep 26; Vol. 2023, pp. 9947797. Date of Electronic Publication: 2023 Sep 26 (Print Publication: 2023).
Typ publikacji:
Systematic Review; Meta-Analysis; Journal Article; Review
MeSH Terms:
Granulomatous Mastitis*/drug therapy
Granulomatous Mastitis*/diagnosis
Breast Neoplasms*
Pregnancy ; Female ; Humans ; Adult ; Quality of Life ; Neoplasm Recurrence, Local ; Immunosuppressive Agents/therapeutic use ; Anti-Bacterial Agents/therapeutic use ; Contraceptive Agents/therapeutic use ; Recurrence
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Unravelling the role of immune cells and FN1 in the recurrence and therapeutic process of skull base chordoma.
Autorzy:
Huo X; Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Ma S; Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Wang C; Department of Neuro-oncology, Cancer Center, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Song L; Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Yao B; Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Zhu S; Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Li P; Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Wang L; Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Wu Z; Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Wang K; Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Pokaż więcej
Źródło:
Clinical and translational medicine [Clin Transl Med] 2023 Oct; Vol. 13 (10), pp. e1429.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Chordoma*/genetics
Chordoma*/metabolism
Chordoma*/pathology
Skull Base Neoplasms*/genetics
Skull Base Neoplasms*/metabolism
Skull Base Neoplasms*/pathology
Head and Neck Neoplasms*
Humans ; Animals ; Mice ; Fibronectins ; Neoplasm Recurrence, Local/genetics ; Neoplasm Recurrence, Local/pathology ; Treatment Outcome ; Skull Base/metabolism ; Skull Base/pathology ; Tumor Microenvironment
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Benign Phyllodes Tumors: Comparison of Prognosis among Three Different Surgical Approaches.
Autorzy:
Jiang Y; School of Medicine, Nankai University, 94 Weijin Road, Tianjin 300071, China.
Wang B; Department of Ultrasound, Chinese People's Liberation Army General Hospital, 28 Fuxing Road, Beijing 100853, China.
Li JK; Department of Ultrasound, Chinese People's Liberation Army General Hospital, 28 Fuxing Road, Beijing 100853, China.
Li SY; Department of Ultrasound, Chinese People's Liberation Army General Hospital, 28 Fuxing Road, Beijing 100853, China.
Niu RL; Department of Ultrasound, Chinese People's Liberation Army General Hospital, 28 Fuxing Road, Beijing 100853, China.
Fu NQ; Department of Ultrasound, Chinese People's Liberation Army General Hospital, 28 Fuxing Road, Beijing 100853, China.
Zheng JJ; Department of Ultrasound, Chinese People's Liberation Army General Hospital, 28 Fuxing Road, Beijing 100853, China.
Liu G; Department of Radiology, Chinese People's Liberation Army General Hospital, 28 Fuxing Road, Beijing 100853, China.
Wang ZL; School of Medicine, Nankai University, 94 Weijin Road, Tianjin 300071, China.; Department of Ultrasound, Chinese People's Liberation Army General Hospital, 28 Fuxing Road, Beijing 100853, China.
Pokaż więcej
Źródło:
The breast journal [Breast J] 2023 Sep 20; Vol. 2023, pp. 1682084. Date of Electronic Publication: 2023 Sep 20 (Print Publication: 2023).
Typ publikacji:
Journal Article
MeSH Terms:
Breast Neoplasms*/surgery
Breast Neoplasms*/pathology
Phyllodes Tumor*/surgery
Phyllodes Tumor*/pathology
Humans ; Female ; Margins of Excision ; Retrospective Studies ; Neoplasm Recurrence, Local/pathology ; Prognosis
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Talimogene laherparepvec pseudolymphomatous reaction mimicking metastatic melanoma.
Autorzy:
Henning A; Summa Health, Akron, Ohio, USA.
Agnese D; Department of Surgical Oncology, The Ohio State University, Columbus, Ohio, USA.
Chung CG; Department of Medicine, Division of Dermatology, The Ohio State University, Columbus, Ohio, USA.; Department of Pathology, The Ohio State University, Columbus, Ohio, USA.
Pokaż więcej
Źródło:
Journal of cutaneous pathology [J Cutan Pathol] 2021 Nov; Vol. 48 (11), pp. 1423-1426. Date of Electronic Publication: 2021 Jul 08.
Typ publikacji:
Case Reports
MeSH Terms:
Antineoplastic Agents, Immunological/*adverse effects
Biological Products/*adverse effects
Melanoma/*therapy
Neoplasm Recurrence, Local/*pathology
Skin Neoplasms/*therapy
Adult ; Diagnosis, Differential ; Herpesvirus 1, Human ; Humans ; Male ; Neoplasm Recurrence, Local/diagnosis ; Melanoma, Cutaneous Malignant
Raport
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Integrating real-time in vivo tumour genomes for longitudinal analysis and management of glioma recurrence.
Autorzy:
Sheng Z; Department of Neurosurgery, Zhengzhou University People's Hospital, Henan Provincial People's Hospital, Zhengzhou, China.; Juha International Central Laboratory of Neurosurgery, Henan Provincial People's Hospital, Zhengzhou, China.
Yu J; Department of Neurosurgery, Zhengzhou University People's Hospital, Henan Provincial People's Hospital, Zhengzhou, China.; Juha International Central Laboratory of Neurosurgery, Henan Provincial People's Hospital, Zhengzhou, China.
Deng K; Department of Neurosurgery, Zhengzhou University People's Hospital, Henan Provincial People's Hospital, Zhengzhou, China.; Juha International Central Laboratory of Neurosurgery, Henan Provincial People's Hospital, Zhengzhou, China.
Bu Y; Department of Neurosurgery, Zhengzhou University People's Hospital, Henan Provincial People's Hospital, Zhengzhou, China.; Juha International Central Laboratory of Neurosurgery, Henan Provincial People's Hospital, Zhengzhou, China.
Wu S; Department of Neurosurgery, Zhengzhou University People's Hospital, Henan Provincial People's Hospital, Zhengzhou, China.; Juha International Central Laboratory of Neurosurgery, Henan Provincial People's Hospital, Zhengzhou, China.
Xu S; Department of Neurosurgery, Zhengzhou University People's Hospital, Henan Provincial People's Hospital, Zhengzhou, China.; Juha International Central Laboratory of Neurosurgery, Henan Provincial People's Hospital, Zhengzhou, China.
Gao Y; Department of Neurosurgery, Zhengzhou University People's Hospital, Henan Provincial People's Hospital, Zhengzhou, China.; Juha International Central Laboratory of Neurosurgery, Henan Provincial People's Hospital, Zhengzhou, China.
Zhang Q; Department of Neurosurgery, Zhengzhou University People's Hospital, Henan Provincial People's Hospital, Zhengzhou, China.; Juha International Central Laboratory of Neurosurgery, Henan Provincial People's Hospital, Zhengzhou, China.
Yan Z; Department of Neurosurgery, Zhengzhou University People's Hospital, Henan Provincial People's Hospital, Zhengzhou, China.; Juha International Central Laboratory of Neurosurgery, Henan Provincial People's Hospital, Zhengzhou, China.
Bu C; Juha International Center for Neurosurgery, Henan Provincial People's Hospital, Zhengzhou, China.; Juha International Central Laboratory of Neurosurgery, Henan Provincial People's Hospital, Zhengzhou, China.
Chen Z; Juha International Center for Neurosurgery, Henan Provincial People's Hospital, Zhengzhou, China.; Juha International Central Laboratory of Neurosurgery, Henan Provincial People's Hospital, Zhengzhou, China.
Gu J; Juha International Center for Neurosurgery, Henan Provincial People's Hospital, Zhengzhou, China.; Juha International Central Laboratory of Neurosurgery, Henan Provincial People's Hospital, Zhengzhou, China.
Jia Y; Department of Neurology, Henan Provincial People's Hospital, Zhengzhou, China.; Laboratory of Neurology, Henan Provincial People's Hospital, Zhengzhou, China.
Gao X; Department of Neurology, Henan Provincial People's Hospital, Zhengzhou, China.; Laboratory of Neurology, Henan Provincial People's Hospital, Zhengzhou, China.
Zemmar A; Juha International Center for Neurosurgery, Henan Provincial People's Hospital, Zhengzhou, China.; Juha International Central Laboratory of Neurosurgery, Henan Provincial People's Hospital, Zhengzhou, China.
Sumardi F; Juha International Center for Neurosurgery, Henan Provincial People's Hospital, Zhengzhou, China.; Juha International Central Laboratory of Neurosurgery, Henan Provincial People's Hospital, Zhengzhou, China.
Hernesniemi J; Juha International Center for Neurosurgery, Henan Provincial People's Hospital, Zhengzhou, China.; Juha International Central Laboratory of Neurosurgery, Henan Provincial People's Hospital, Zhengzhou, China.
Kong L; Department of Pathology, Henan Provincial People's Hospital, Zhengzhou, China.
Liu G; Department of Center for Clinical Single Cell Biomedicine, Clinical Research Center, Department of Oncology, Henan Provincial People's Hospital, The People's Hospital of Zhengzhou University, Zhengzhou, China.
Li M; Department of Neurosurgery, Zhengzhou University People's Hospital, Henan Provincial People's Hospital, Zhengzhou, China.; Juha International Central Laboratory of Neurosurgery, Henan Provincial People's Hospital, Zhengzhou, China.
Wang M; Department of Radiology, Henan Provincial People's Hospital, Zhengzhou, China.
Li T; Juha International Center for Neurosurgery, Henan Provincial People's Hospital, Zhengzhou, China.; Juha International Central Laboratory of Neurosurgery, Henan Provincial People's Hospital, Zhengzhou, China.
Bu X; Department of Neurosurgery, Zhengzhou University People's Hospital, Henan Provincial People's Hospital, Zhengzhou, China.; Juha International Central Laboratory of Neurosurgery, Henan Provincial People's Hospital, Zhengzhou, China.
Pokaż więcej
Źródło:
Clinical and translational medicine [Clin Transl Med] 2021 Nov; Vol. 11 (11), pp. e567.
Typ publikacji:
Letter; Research Support, Non-U.S. Gov't
MeSH Terms:
Time Factors*
Glioma/*genetics
Neoplasm Recurrence, Local/*genetics
Neoplasms/*genetics
Glioma/pathology ; Humans ; Neoplasm Recurrence, Local/physiopathology ; Neoplasms/pathology
Raport
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
A systematic review of fear of cancer recurrence related healthcare use and intervention cost-effectiveness.
Autorzy:
Williams JTW; School of Public Health, University of Sydney, Sydney, New South Wales, Australia.
Pearce A; School of Public Health, University of Sydney, Sydney, New South Wales, Australia.
Smith A'; Ingham Institute for Applied Medical Research, Sydney, New South Wales, Australia.; South Western Sydney Clinical School, University of New South Wales, Liverpool, New South Wales, Australia.
Pokaż więcej
Źródło:
Psycho-oncology [Psychooncology] 2021 Aug; Vol. 30 (8), pp. 1185-1195. Date of Electronic Publication: 2021 Apr 20.
Typ publikacji:
Journal Article; Systematic Review
MeSH Terms:
Neoplasm Recurrence, Local*
Quality of Life*
Adult ; Humans ; Cost-Benefit Analysis ; Delivery of Health Care ; Fear
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Genomewide transcriptomic profiling identifies a gene signature for predicting recurrence in early-stage hepatocellular carcinoma.
Autorzy:
Kakisaka T; Center for Gastrointestinal Research, Center from Translational Genomics and Oncology, Baylor Scott and White Research Institute and Charles A. Sammons Cancer Center, Baylor University Medical Center, Dallas, Texas, USA.; Department of Molecular Diagnostics and Experimental Therapeutics, Beckman Research Institute of City of Hope Comprehensive Cancer Center, Duarte, California, USA.
Fukai M; Department of Gastroenterological Surgery I, Graduate School of Medicine, Hokkaido University, Hokkaido, Japan.
Banwait JK; Center for Gastrointestinal Research, Center from Translational Genomics and Oncology, Baylor Scott and White Research Institute and Charles A. Sammons Cancer Center, Baylor University Medical Center, Dallas, Texas, USA.
Kamiyama T; Department of Gastroenterological Surgery I, Graduate School of Medicine, Hokkaido University, Hokkaido, Japan.
Orimo T; Department of Gastroenterological Surgery I, Graduate School of Medicine, Hokkaido University, Hokkaido, Japan.
Mitsuhashi T; Department of Surgical Pathology, Hokkaido University Hospital, Hokkaido, Japan.
Yamamura K; Department of Gastroenterological Surgery, Graduate School of Medical Science, Kumamoto University, Kumamoto, Japan.
Toshima T; Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Baba H; Department of Gastroenterological Surgery, Graduate School of Medical Science, Kumamoto University, Kumamoto, Japan.
Taketomi A; Department of Gastroenterological Surgery I, Graduate School of Medicine, Hokkaido University, Hokkaido, Japan.
Goel A; Center for Gastrointestinal Research, Center from Translational Genomics and Oncology, Baylor Scott and White Research Institute and Charles A. Sammons Cancer Center, Baylor University Medical Center, Dallas, Texas, USA.; Department of Molecular Diagnostics and Experimental Therapeutics, Beckman Research Institute of City of Hope Comprehensive Cancer Center, Duarte, California, USA.
Pokaż więcej
Źródło:
Clinical and translational medicine [Clin Transl Med] 2021 Jun; Vol. 11 (6), pp. e405.
Typ publikacji:
Letter; Research Support, N.I.H., Extramural
MeSH Terms:
Gene Expression Regulation, Neoplastic*
Transcriptome*
Biomarkers, Tumor/*genetics
Carcinoma, Hepatocellular/*pathology
Liver Neoplasms/*pathology
Neoplasm Recurrence, Local/*pathology
Aged ; Carcinoma, Hepatocellular/genetics ; Carcinoma, Hepatocellular/surgery ; Female ; Follow-Up Studies ; Genome-Wide Association Study ; Humans ; Liver Neoplasms/genetics ; Liver Neoplasms/surgery ; Male ; Neoplasm Recurrence, Local/genetics ; Neoplasm Recurrence, Local/surgery ; Prognosis ; RNA-Seq ; Survival Rate
Raport
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Post-operative minimal residual disease models to study metastatic relapse in soft-tissue sarcoma patient-derived xenografts.
Autorzy:
Fischer S; Laboratory of Experimental Cancer Research, Department of Human Structure and Repair, Ghent University, Ghent, Belgium.; Department of Gastro-Intestinal Surgery, Ghent University Hospital, Ghent, Belgium.; Cancer Research Institute Ghent, Ghent, Belgium.
Creytens D; Cancer Research Institute Ghent, Ghent, Belgium.; Department of Pathology, Ghent University Hospital, Ghent, Belgium.
De Geyter S; Laboratory of Experimental Cancer Research, Department of Human Structure and Repair, Ghent University, Ghent, Belgium.
De Vlieghere E; Laboratory of Experimental Cancer Research, Department of Human Structure and Repair, Ghent University, Ghent, Belgium.; Cancer Research Institute Ghent, Ghent, Belgium.
Pattyn P; Department of Gastro-Intestinal Surgery, Ghent University Hospital, Ghent, Belgium.
Bekaert SL; Cancer Research Institute Ghent, Ghent, Belgium.; Department of Biomolecular Medicine, Ghent University, Ghent, Belgium.
Durinck K; Cancer Research Institute Ghent, Ghent, Belgium.; Pediatric Precision Oncology Lab, Ghent University, Ghent, Belgium.; Centre for Medical Genetics, Ghent University Hospital, Ghent, Belgium.
Van Roy N; Cancer Research Institute Ghent, Ghent, Belgium.; Department of Biomolecular Medicine, Ghent University, Ghent, Belgium.; Pediatric Precision Oncology Lab, Ghent University, Ghent, Belgium.
Hendrix A; Laboratory of Experimental Cancer Research, Department of Human Structure and Repair, Ghent University, Ghent, Belgium.; Cancer Research Institute Ghent, Ghent, Belgium.
Lapeire L; Cancer Research Institute Ghent, Ghent, Belgium.; Department of Medical Oncology, Ghent University Hospital, Ghent, Belgium.
Sys G; Cancer Research Institute Ghent, Ghent, Belgium.; Department of Orthopedics and Traumatology, Ghent University Hospital, Ghent, Belgium.
De Wever O; Laboratory of Experimental Cancer Research, Department of Human Structure and Repair, Ghent University, Ghent, Belgium.; Cancer Research Institute Ghent, Ghent, Belgium.
Pokaż więcej
Źródło:
Clinical and translational medicine [Clin Transl Med] 2023 Jun; Vol. 13 (6), pp. e1290.
Typ publikacji:
Letter
MeSH Terms:
Sarcoma*/pathology
Sarcoma*/surgery
Soft Tissue Neoplasms*/pathology
Soft Tissue Neoplasms*/surgery
Animals ; Humans ; Neoplasm, Residual ; Heterografts ; Neoplasm Recurrence, Local ; Disease Models, Animal
Opinia redakcyjna
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
PD1 exhausted T cell increase immunotherapy resistance and tumour progression by promoting epithelial-mesenchymal transition in bladder cancer.
Autorzy:
Wu C; State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, P. R. China.
Duan L; School of Life Sciences, Zhengzhou University, Zhengzhou, P. R. China.
Li H; State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, P. R. China.; Department of Thoracic Oncology, Sun Yat-sen University Cancer Center, Guangzhou, P. R. China.
Liu X; School of Medicine, Southern University of Science and Technology, Shenzhen, P. R. China.; Shenzhen Institute of Pediatrics, Shenzhen Children's Hospital, Shenzhen, P. R. China.
Cai T; Department of Urology, Sun Yat-sen University Cancer Center, Guangzhou, P. R. China.
Yang Y; School of Geography and Environmental Sciences, Northwest Normal University, Lanzhou, P. R. China.
Yin Y; State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, P. R. China.
Chang W; State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, P. R. China.; Department of Thoracic Oncology, Sun Yat-sen University Cancer Center, Guangzhou, P. R. China.
Zhong L; State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, P. R. China.; Department of Thoracic Oncology, Sun Yat-sen University Cancer Center, Guangzhou, P. R. China.
Zhang L; State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, P. R. China.; Department of Clinical Laboratory, Sun Yat-Sen University Cancer Center, Guangzhou, P. R. China.
Cheng Y; State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, P. R. China.
Qin H; Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, P. R. China.
Wen Z; State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, P. R. China.; Department of Thoracic Oncology, Sun Yat-sen University Cancer Center, Guangzhou, P. R. China.
Wang H; State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, P. R. China.
Mai S; State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, P. R. China.
Pokaż więcej
Źródło:
Clinical and translational medicine [Clin Transl Med] 2023 Jun; Vol. 13 (6), pp. e1303.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Epithelial-Mesenchymal Transition*
Urinary Bladder Neoplasms*/therapy
Humans ; T-Lymphocytes ; Neoplasm Recurrence, Local ; CD4-Positive T-Lymphocytes ; Tumor Microenvironment ; Methyltransferases
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Integrated metabolic and genetic analysis reveals distinct features of human differentiated thyroid cancer.
Autorzy:
Cararo Lopes E; Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA.; Department of Molecular Biology and Biochemistry, Rutgers University, Piscataway, New Jersey, USA.
Sawant A; Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA.
Moore D; Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA.; Department of Biostatistics and Epidemiology, Rutgers School of Public Health, Piscataway, New Jersey, USA.
Ke H; Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA.
Shi F; Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA.
Laddha S; Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA.
Chen Y; Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA.
Sharma A; Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA.
Naumann J; Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA.
Guo JY; Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA.; Department of Medicine, Robert Wood Johnson Medical School, Rutgers University, New Brunswick, New Jersey, USA.; Department of Chemical Biology, Rutgers Ernest Mario School of Pharmacy, Piscataway, New Jersey, USA.
Gomez M; Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA.
Ibrahim M; Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA.
Smith TL; Rutgers Cancer Institute of New Jersey, Newark, New Jersey, USA.; Division of Cancer Biology, Department of Radiation Oncology, Rutgers New Jersey Medical School, Newark, New Jersey, USA.
Riedlinger GM; Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA.
Lattime EC; Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA.; Department of Surgery, Robert Wood Johnson Medical School, Rutgers University, New Brunswick, New Jersey, USA.
Trooskin S; Department of Surgery, Robert Wood Johnson Medical School, Rutgers University, New Brunswick, New Jersey, USA.
Ganesan S; Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA.; Department of Medicine, Robert Wood Johnson Medical School, Rutgers University, New Brunswick, New Jersey, USA.
Su X; Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA.; Department of Medicine, Robert Wood Johnson Medical School, Rutgers University, New Brunswick, New Jersey, USA.
Pasqualini R; Rutgers Cancer Institute of New Jersey, Newark, New Jersey, USA.; Division of Cancer Biology, Department of Radiation Oncology, Rutgers New Jersey Medical School, Newark, New Jersey, USA.
Arap W; Rutgers Cancer Institute of New Jersey, Newark, New Jersey, USA.; Division of Hematology/Oncology, Department of Medicine, Rutgers New Jersey Medical School, Newark, New Jersey, USA.
De S; Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA.
Chan CS; Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA.; Department of Medicine, Robert Wood Johnson Medical School, Rutgers University, New Brunswick, New Jersey, USA.
White E; Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA.; Department of Molecular Biology and Biochemistry, Rutgers University, Piscataway, New Jersey, USA.; Ludwig Princeton Branch, Ludwig Institute for Cancer Research, Princeton University, Princeton, New Jersey, USA.
Pokaż więcej
Źródło:
Clinical and translational medicine [Clin Transl Med] 2023 Jun; Vol. 13 (6), pp. e1298.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
MeSH Terms:
Thyroid Neoplasms*/diagnosis
Thyroid Neoplasms*/genetics
Adenocarcinoma*
Humans ; Iodine Radioisotopes/therapeutic use ; Prospective Studies ; Quality of Life ; Telomere Shortening ; Telomere ; Neoplasm Recurrence, Local
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Cryoablation inhibits the recurrence and progression of bladder cancer by enhancing tumour-specific immunity.
Autorzy:
Mou Z; Department of Urology, Huashan Hospital, Fudan University, Shanghai, China.
Chen Y; Department of Urology, Huashan Hospital, Fudan University, Shanghai, China.
Zhang Z; Department of Urology, Huashan Hospital, Fudan University, Shanghai, China.
Chen X; Department of Urology, Huashan Hospital, Fudan University, Shanghai, China.
Hu Y; Department of Urology, Huashan Hospital, Fudan University, Shanghai, China.
Zou L; Department of Urology, Huashan Hospital, Fudan University, Shanghai, China.
Xu C; Department of Urology, Huashan Hospital, Fudan University, Shanghai, China.
Jiang H; Department of Urology, Huashan Hospital, Fudan University, Shanghai, China.; Fudan Institute of Urology, Fudan University, Shanghai, China.; National Clinical Research Center for Aging and Medicine, Fudan University, Shanghai, China.
Pokaż więcej
Źródło:
Clinical and translational medicine [Clin Transl Med] 2023 May; Vol. 13 (5), pp. e1255.
Typ publikacji:
Systematic Review; Journal Article
MeSH Terms:
Cryosurgery*
Urinary Bladder Neoplasms*/surgery
Urinary Bladder Neoplasms*/pathology
Humans ; Animals ; Mice ; Neoplasm Recurrence, Local/surgery ; Prognosis ; T-Lymphocytes ; Tumor Microenvironment
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Rituximab, Cyclophosphamide and Dexamethasone (RCD) Chemoimmunotherapy for Relapsed Chronic Lymphocytic Leukaemia.
Autorzy:
Šimkovič M; 4th Department of Internal Medicine - Haematology, Faculty of Medicine in Hradec Králové, University Hospital and Charles University in Prague, Hradec Kralove, Czech Republic.
Vodárek P; 4th Department of Internal Medicine - Haematology, Faculty of Medicine in Hradec Králové, University Hospital and Charles University in Prague, Hradec Kralove, Czech Republic.
Motyčková M; 4th Department of Internal Medicine - Haematology, Faculty of Medicine in Hradec Králové, University Hospital and Charles University in Prague, Hradec Kralove, Czech Republic.
Écsiová D; 4th Department of Internal Medicine - Haematology, Faculty of Medicine in Hradec Králové, University Hospital and Charles University in Prague, Hradec Kralove, Czech Republic.
Rozsívalová P; Department of Clinical Pharmacy, Hospital Pharmacy, Faculty of Medicine in Hradec Králové, University Hospital and Charles University in Prague, Hradec Kralove, Czech Republic.
Móciková H; Institute of Clinical Biochemistry and Diagnostics, University Hospital Hradec Králové, Hradec Králové, Czech Republic.
Štěpánková P; 4th Department of Internal Medicine - Haematology, Faculty of Medicine in Hradec Králové, University Hospital and Charles University in Prague, Hradec Kralove, Czech Republic.
Sýkorová A; 4th Department of Internal Medicine - Haematology, Faculty of Medicine in Hradec Králové, University Hospital and Charles University in Prague, Hradec Kralove, Czech Republic.
Hrochová K; Department of Internal Medicine and Haematology, University Hospital Královské Vinohrady and Third Faculty of Medicine, Charles University, Prague, Czech Republic.
Vrbacký F; 4th Department of Internal Medicine - Haematology, Faculty of Medicine in Hradec Králové, University Hospital and Charles University in Prague, Hradec Kralove, Czech Republic.
Belada D; 4th Department of Internal Medicine - Haematology, Faculty of Medicine in Hradec Králové, University Hospital and Charles University in Prague, Hradec Kralove, Czech Republic.
Žák P; 4th Department of Internal Medicine - Haematology, Faculty of Medicine in Hradec Králové, University Hospital and Charles University in Prague, Hradec Kralove, Czech Republic.
Smolej L; 4th Department of Internal Medicine - Haematology, Faculty of Medicine in Hradec Králové, University Hospital and Charles University in Prague, Hradec Kralove, Czech Republic.
Pokaż więcej
Źródło:
European journal of clinical investigation [Eur J Clin Invest] 2021 Apr; Vol. 51 (4), pp. e13421. Date of Electronic Publication: 2020 Oct 22.
Typ publikacji:
Journal Article
MeSH Terms:
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Leukemia, Lymphocytic, Chronic, B-Cell/*drug therapy
Neoplasm Recurrence, Local/*drug therapy
Aged ; Aged, 80 and over ; Cyclophosphamide/administration & dosage ; Dexamethasone/administration & dosage ; Diabetes Mellitus/chemically induced ; Diabetes Mellitus/epidemiology ; Drug Tapering ; Female ; Humans ; Infections/epidemiology ; Leukemia, Lymphocytic, Chronic, B-Cell/genetics ; Leukemia, Lymphocytic, Chronic, B-Cell/pathology ; Male ; Middle Aged ; Neoplasm Recurrence, Local/genetics ; Neoplasm Recurrence, Local/pathology ; Neoplasm Staging ; Neutropenia/chemically induced ; Neutropenia/epidemiology ; Progression-Free Survival ; Remission Induction ; Retrospective Studies ; Rituximab/administration & dosage ; Survival Rate ; Treatment Outcome ; Tumor Suppressor Protein p53/genetics
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 1-20 z 6713

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies